This webinar will consist of the following presentations:
‘The continuing challenges of treating surgical site infections – a surgeon’s perspective’
Treatment options and pathways. Where does a new fluoroquinolone sit?
Professor Shervanthi Homer-Vanniasinkam is a Consultant Vascular Surgeon at Leeds Teaching Hospitals NHS Trust. She is also the Founding Director of EXSEL (a novel medical student scholarship scheme), at the University of Leeds Medical School, the Founding Professor of Surgery at the University of Warwick Medical School & University Hospitals Coventry and Warwickshire, and Professor of Engineering & Surgery at University College London.
She has published 150 papers and book chapters (H index 40), delivered over 300 presentations, and has a significant research grant portfolio. She has an outstanding track record of national (Universities of Leeds, London, Warwick) and international (Harvard, Yale, Singapore, India, Sri Lanka) collaborative research. She is a Visiting Scholar at Harvard University, the Yeoh Ghim Seng Visiting Professor of Surgery at the National University of Singapore and the Brahm Prakash Visiting Professor at the Indian Institute of Science.
Prof. Mark Wilcox is a consultant microbiologist and the Head of Research and Development in Microbiology at the Leeds Teaching Hospitals (LTHT), where he is also the Infection Lead of Leeds NIHR Diagnostic Technologies Medical Technology and In Vitro Diagnostic Co-operative; Professor of Medical Microbiology at the University of Leeds; and Lead on Clostridium difficile for Public Health England (PHE). He serves in multiple advisory roles including to UK SAGE (COVID-19), as a medical advisor to the National Infection Prevention & Control Lead (NHSImprovement/England, the Medical Research Council’s Infection and Immunity Panel, as Chair of PHE’s Rapid Review Panel (reviews the utility of infection prevention & control products for the NHS) and member of the UK NHS Antimicrobial Resistance Programme Board.
He was formerly the Director of Infection Prevention (4 years), Infection Control Doctor (8 years), and Clinical Director of Pathology (6 years) at LTHT and Head of Microbiology (15 years).
Prof Wilcox leads a Healthcare Associated Infection Research Group at the University of Leeds (http://medhealth.leeds.ac.uk/hcai), comprising ~30 doctors, scientists and nurses. Projects include multiple aspects of Clostridium difficile infection, diagnostics, antibiotic resistance and the gut microbiome, infection prevention and control interventions, and the clinical development of new antimicrobial agents.
For any Delegates joining our webinars, the following browsers are supported:
Please use Chrome, Firefox, Safari and Edge.
Here are the minimum version requirements for each browser:
Delegates joining a webinar via their mobile will be able to join directly through their Unique Join Link issued at registration.